psilocybin
The psychoactive compound in 'magic mushrooms' currently being studied for therapeutic uses.
As defined in 267 | Benjamin Breen on Margaret Mead, Psychedelics, and Utopia
Other definitions
A naturally occurring psychedelic compound found in certain mushroom species; mentioned in the transcript in the context of sub-macroscopic ('microdose') dosing in the range of 0.75-1 gram, compared against therapeutic doses of approximately 2.2 grams for treatment-resistant depression.
Why Drinkers Can’t Stand Non-Drinkers - Andrew Huberman
Where it comes up · 41
- How Psilocybin Can Rewire Our Brain, Its Therapeutic Benefits & Its Risks28 claims
- 177 - Psychedelic Science12 claims
- 127 - Freedom From The Known7 claims
- 306 - Psychedelics Mortality6 claims
- 209 - A Good Life3 claims
- 242 - Psychedelics And The Self3 claims
- 286 - The Paradox Of Psychedelics3 claims
- 82 | Robin Carhart-Harris on Psychedelics and the Brain3 claims
and 33 more
Most important claims · 10 of 106Search all claims for “psilocybin” →
- A small proof-of-concept pilot study led by Matt Johnson at Johns Hopkins showed 80% biologically verified abstinence at six months among addicted smokers treated with psilocybin, an unheard-of rate in the cigarette cessation field, now being followed up with a randomized controlled trial; this and trials in alcoholism and cocaine dependence suggest psilocybin has cross-diagnostic efficacy as a higher-order effect rather than a single receptor-targeted mechanism.177 - Psychedelic Science
- Under optimized supportive conditions of preparation, set and setting, psilocybin can reliably occasion a constellation of mystical-type experiences in a high proportion of prepared volunteers (around 80%), characterized by six features: unity, sacredness/preciousness, the noetic sense, positive mood, transcendence of time and space, and ineffability.177 - Psychedelic Science
- In published studies at Johns Hopkins and NYU, a single psilocybin session in cancer patients with significant psychological distress produced immediate and very substantial decreases in depression and anxiety lasting out to six months and presumably much longer, an indication Griffiths considered ideal for reintroducing psychedelics because concerns about addiction become irrelevant for terminal patients.177 - Psychedelic Science
- New medicines—especially psychedelics—should be introduced into culture in a staged, careful way with understanding of the social and cultural roles they play, rather than treated as a magic-bullet wonder drug; the failure to embed substances in social context repeatedly causes harm, as with opioids marketed as a cure for pain.267 | Benjamin Breen on Margaret Mead, Psychedelics, and Utopia
- Classic psychedelics like psilocybin have an excellent toxicity profile with a massive therapeutic index (large gap between an effective dose and a harmful one), negligible addiction potential (animals do not self-administer them and they are fundamentally aversive), and no physiological mortality risk—the main dangers being behavioral and psychological vulnerability.82 | Robin Carhart-Harris on Psychedelics and the Brain
- Psilocybin is essentially serotonin in that its main effect is to mimic serotonin, but it does so in a very specific way by activating a subset of serotonin receptors in a very strong fashion, specifically the serotonin 2A receptor, leading to neuroplasticity at the level of neural circuits that serve memory and perception.How Psilocybin Can Rewire Our Brain, Its Therapeutic Benefits & Its Risks
- Psychiatry has repeatedly been swept up in unscientific hype—the 1920s-30s violent psychosomatic interventions that won Nobel Prizes, the 1980s biological turn, and now psychedelics—and this cycle recurs because the hype serves pharmaceutical companies who profit (often by patenting substances indigenous communities used for millennia) and academic psychiatrists who build careers on it.Marco Ramos on Misunderstanding Mental Illness
- Months after a single high-dose psilocybin session, about 80-90% of volunteers rate the experience among the top five most personally meaningful and spiritually significant experiences of their entire lives, comparing it to the birth of a first child or the death of a parent, a level of enduring salience unlike any other psychoactive drug.177 - Psychedelic Science
- In a study giving a moderate dose of psilocybin to long-term meditators on a retreat, the experiences deepened their practice and engagement, with deeper psilocybin experiences predicting more positive enduring effects at four months; even meditators with tens of thousands of hours found the experiences informative, though less discontinuous with expectation because they are accustomed to de-identifying with objects in mind.177 - Psychedelic Science
- A recently published study put expert meditators on a five-day silent retreat and gave half psilocybin on day four; at four-month follow-up the psilocybin group looked nothing like controls on measures of appreciation for life, self-acceptance, concern for society, sense of purpose, and reduced death anxiety, and compared to other psilocybin studies mindfulness appeared to increase these positive effects while minimizing negative experiences.177 - Psychedelic Science